Brief: Virios Therapeutics Announces Publication of International Patent For IMC-2 Covering Antiviral Treatment Of Long-COVID
26/03/2024 13:20
March 26 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES PUBLICATION OF INTERNATIONAL
PATENT FOR IMC-2 COVERING ANTIVIRAL TREATMENT OF LONG-COVID
Source text for Eikon: ID:nGNX4VSW9L
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study